17-beta estradiol

DRUG4 trials

Sponsors

Novo Nordisk A/S, One Fertility, Aarhus University Hospital

Conditions

Estrogen DeficiencyEstrogen Replacement TherapyGenetic DisorderHormone Replacement TherapyHypogonadism; OvarianIVFTurner Syndrome

Phase 2

Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles

One FertilityIVF

Start: 2016-05-31End: 2018-06-30Target: 506Updated: 2016-02-10

Phase 3

Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome

CompletedNCT01710696

Novo Nordisk A/SGenetic Disorder, Turner Syndrome

Start: 1998-07-23End: 2004-07-26Updated: 2017-02-28

Phase 4

Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome

RecruitingNCT06544473

Aarhus University HospitalEstrogen Deficiency, Estrogen Replacement Therapy, Hormone Replacement Therapy +2

Start: 2021-11-29End: 2026-12-31Target: 50Updated: 2024-08-23

Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome

RecruitingNCT06570460

Aarhus University HospitalEstrogen Deficiency, Estrogen Replacement Therapy, Hormone Replacement Therapy +2

Start: 2021-11-29End: 2026-12-31Target: 50Updated: 2024-08-26